Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 1
1977 1
1979 4
1980 4
1982 2
1984 2
1985 1
1986 1
1987 1
1988 1
1989 4
1990 3
1991 1
1992 3
1993 5
1994 4
1995 4
1996 7
1997 8
1998 8
1999 8
2000 7
2001 15
2002 13
2003 19
2004 14
2005 13
2006 10
2007 11
2008 14
2009 10
2010 11
2011 8
2012 16
2013 7
2014 2
2015 4
2016 4
2017 5
2018 2
2019 1
2020 1
2021 1
2022 2
2023 4
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D. Scagliotti GV, et al. Among authors: manegold c. J Clin Oncol. 2008 Jul 20;26(21):3543-51. doi: 10.1200/JCO.2007.15.0375. Epub 2008 May 27. J Clin Oncol. 2008. PMID: 18506025 Clinical Trial.
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, Lim HL, Desch C, Szondy K, Gervais R, Shaharyar, Manegold C, Paul S, Paoletti P, Einhorn L, Bunn PA Jr. Hanna N, et al. Among authors: manegold c. J Clin Oncol. 2004 May 1;22(9):1589-97. doi: 10.1200/JCO.2004.08.163. J Clin Oncol. 2004. PMID: 15117980 Clinical Trial.
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer.
Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D. Scagliotti GV, et al. Among authors: manegold c. J Clin Oncol. 2023 May 10;41(14):2458-2466. doi: 10.1200/JCO.22.02544. J Clin Oncol. 2023. PMID: 37146426 Clinical Trial.
Bone matters in lung cancer.
Brodowicz T, O'Byrne K, Manegold C. Brodowicz T, et al. Among authors: manegold c. Ann Oncol. 2012 Sep;23(9):2215-2222. doi: 10.1093/annonc/mds009. Epub 2012 Feb 22. Ann Oncol. 2012. PMID: 22357445 Free PMC article. Review.
Bevacizumab-induced hypertension: pathogenesis and management.
Syrigos KN, Karapanagiotou E, Boura P, Manegold C, Harrington K. Syrigos KN, et al. Among authors: manegold c. BioDrugs. 2011 Jun 1;25(3):159-69. doi: 10.2165/11590180-000000000-00000. BioDrugs. 2011. PMID: 21627340 Review.
Advanced NSCLC: new cytostatic agents.
Kosmidis PA, Manegold C. Kosmidis PA, et al. Among authors: manegold c. Lung Cancer. 2003 Aug;41 Suppl 1:S123-32. doi: 10.1016/s0169-5002(03)00156-9. Lung Cancer. 2003. PMID: 12867071 Review.
Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Gridelli C, Ardizzoni A, Douillard JY, Hanna N, Manegold C, Perrone F, Pirker R, Rosell R, Shepherd FA, De Petris L, Di Maio M, de Marinis F. Gridelli C, et al. Among authors: manegold c. Lung Cancer. 2010 Jun;68(3):319-31. doi: 10.1016/j.lungcan.2009.11.018. Epub 2009 Dec 24. Lung Cancer. 2010. PMID: 20036027 Review.
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC.
Manegold C, Dingemans AC, Gray JE, Nakagawa K, Nicolson M, Peters S, Reck M, Wu YL, Brustugun OT, Crinò L, Felip E, Fennell D, Garrido P, Huber RM, Marabelle A, Moniuszko M, Mornex F, Novello S, Papotti M, Pérol M, Smit EF, Syrigos K, van Meerbeeck JP, van Zandwijk N, Yang JC, Zhou C, Vokes E. Manegold C, et al. J Thorac Oncol. 2017 Feb;12(2):194-207. doi: 10.1016/j.jtho.2016.10.003. Epub 2016 Oct 8. J Thorac Oncol. 2017. PMID: 27729297 Free article. Review.
250 results